Cargando…

Clinical response to the canakinumab in crohn’s disease related artrhritis

Detalles Bibliográficos
Autores principales:	Gündüz, Zübeyde, Düşünsel, Ruhan, Aslan, Duran, Sözeri, Betül, Kısaarslan, Ayşenur Paç
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191691/ http://dx.doi.org/10.1186/1546-0096-12-S1-P346

Ejemplares similares

Systemic vasculitis in a child mimicking mercury poisoning
por: Gündüz, Zübeyde, et al.
Publicado: (2014)

Diagnosis of early-onset sarcoidosis with non–classical symptoms
por: Gündüz, Zübeyde, et al.
Publicado: (2014)

Macrophage activation syndrome (MAS) in different pediatric rheumatic disease
por: Gunduz, Zubeyde, et al.
Publicado: (2014)

The diagnosis of juvenile systemic lupus erythematosus with SLICC
por: Kısaarslan, Ayşenur Paç, et al.
Publicado: (2014)

Evaluation of the thicknesses of cartilage and enthesis in familial Mediterranean fever and enthesitis-related arthritis
por: Kisaarslan, Aysenur Pac, et al.
Publicado: (2020)

Clinical and subclinical features and MEFV mutation distribution in of FMF patients’ siblings
por: Gunduz, Z, et al.
Publicado: (2015)

Oxidant and antioxidant status in children with juvenile idiopathic athritis
por: Poyrazoglu, Hakan M, et al.
Publicado: (2011)

Amyloidosis in a child with Hyperimmunoglobulin D syndrome
por: Dusunsel, Ruhan, et al.
Publicado: (2011)

Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
por: Konukbay, Dilek, et al.
Publicado: (2014)

Clinical experiences with canakinumab as a treatment for autoinflammatory disorders
por: Saperia, C, et al.
Publicado: (2015)

61 The nailfold videocapillaroscopy in pediatric Behçet’s disease: a multi-center study
por: Çakmak, Figen, et al.
Publicado: (2022)

Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients
por: Altay, Derya, et al.
Publicado: (2023)

The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever
por: Sozeri, Betul, et al.
Publicado: (2016)

Canakinumab treat-to target strategies increase complete response rate in CAPS
por: Kuemmerle-Deschner, J, et al.
Publicado: (2015)

Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014)

Gene expression profiling in understanding the molecular pathogenesis of and response to canakinumab therapy in traps
por: Gattorno, M, et al.
Publicado: (2014)

Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
por: Polat, Adem, et al.
Publicado: (2014)

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
por: Antón, J, et al.
Publicado: (2013)

A validation of diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in Turkish children
por: Demirkaya, Erkan, et al.
Publicado: (2011)

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

Indications and efficacy of canakinumab in Familial Mediterranean Fever: report of three cases
por: Tsinti, Maria, et al.
Publicado: (2014)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
por: Gul, A, et al.
Publicado: (2015)

Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
por: Caorsi, R, et al.
Publicado: (2011)

Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients
por: Wulffraat, NM, et al.
Publicado: (2014)

PReS-FINAL-2169: Exposure-response modeling of canakinumab in the avoidance of flares in children with systemic juvenile idiopathic arthritis
por: Xiong, Y, et al.
Publicado: (2013)

The clinical and genetic features of patients with hyper-immunoglobulin D syndrome (HIDS)
por: Sozeri, Betul, et al.
Publicado: (2014)

The role of oxidative stress in determining prognosis in children with FMF and the relationship between markers of oxidative stress and gene mutation
por: Eryavuz, O, et al.
Publicado: (2015)

Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab
por: Brogan, P, et al.
Publicado: (2015)

Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease
por: Brachat, A, et al.
Publicado: (2015)

The IL-1 inhibitor Canakinumab for Familial Mediterranean Fever: the Greek experience in 12 patients
por: Laskari, K, et al.
Publicado: (2015)

Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset
por: Ravelli, A, et al.
Publicado: (2014)

An experience of use of canakinumab IL-1 inhibitor in children with cryopyrin-associated periodic syndromes (CAPS)
por: Salugina, Svetlana O, et al.
Publicado: (2014)

PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients
por: Quartier, P, et al.
Publicado: (2013)

Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
por: Ravelli, A, et al.
Publicado: (2014)

A 45 X male patient with 7Q distal deletion and rearragement with SRY gene translocation; a case report
por: Ökten, Ayşenur, et al.
Publicado: (2013)

“Daily life of CAPS patients treated with canakinumab (Ilaris(®)) : data from the French observational study - ENVOL Study”
por: Koné-Paut, I, et al.
Publicado: (2015)

A refractory heterogeneous Cryopyrin-Associated Periodic Syndrome (CAPS) phenotype related to V198M mutation responds to canakinumab - a case report
por: Hansmann, Sandra, et al.
Publicado: (2011)

Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
por: Konukbay, D, et al.
Publicado: (2015)

Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab
por: Barut, K, et al.
Publicado: (2015)

PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy
por: Nirmala, N, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rt53dfpv743bpqrgrpurtg6bni